Home / Healthcare / Metabolomics

Metabolomics

Published: Jul 2013 | No Of Pages: 266 | Published By: RI Technologies

This report gives an insight into Metabolomics Technologies - Combined/Integrated Systems, Hardware Systems for metabolic analytics, and Software Systems. Estimations and predictions for the total global Metabolomics Technologies' market are given by geographic regions encompassing United States, Canada, Europe, Asia-Pacific, and Japan. Business profiles of more than 25 major companies are discussed in the report. The report covers more than 200 companies that are engaged in Metabolomics research and supply of products and/or services. Major Contract Research Organizations and Universities serving Metabolomics market are also covered in the Corporate Directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. Compilation of Worldwide Patents and Research related to Metabolomics is also provided. A total of 49 graphically represented exhibits complement the text.

1. SCOPE AND METHODOLOGY

2. REPORT SYNOPSIS
2.1 Introduction
2.2 Segmentation of Metabolomics Technologies
Combined Systems
Hardware Systems
Software Systems
2.3 Global Market Analysis
Exhibit 1. Metabolomics - Global Market Estimations & Predictions (2005 - 2020) in US$ Million (Graphical Representation Included)
Exhibit 2. List of Major Metabolomics Companies

3. MARKET DYNAMICS
3.1 Metabolomics – Market Overview
3.2 Global Metabolomics Market
Exhibit 3. Metabolomics - Global Market Estimations & Predictions (2005 - 2020) in US$ Million by Geographic Region for North America, Europe, Japan, Asia-Pacific, and Rest of World (Graphical Representation Included)
Exhibit 4. Metabolomics – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Japan, Asia-Pacific, and Rest of World (Graphical Representation Included)
3.3 North American Metabolomics Market
Exhibit 5. Metabolomics – North American Market Estimations & Predictions (2005 - 2020) in US$ Million by Country for United States, and Canada (Graphical Representation Included)
Exhibit 6. Metabolomics – North American Market Shares (2010, 2015 & 2020) by Country for United States, and Canada (Graphical Representation Included)
3.3 (I) United States Metabolomics Market
3.3 (II) Canadian Metabolomics Market
Exhibit 7. List of Major North American Metabolomics Companies
3.4 European Metabolomics Market
Exhibit 8. Metabolomics – European Market Estimations & Predictions (2005-2020) in US$ Million by Country for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 9. Metabolomics – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden, Russia and Rest of Europe (Graphical Representation Included)
3.4 (I) German Metabolomics Market
3.4 (II) UK Metabolomics Market
3.4 (III) Italian Metabolomics Market
3.4 (IV) Belgian Metabolomics Market
3.4 (V) French Metabolomics Market
3.4 (VI) Spanish Metabolomics Market
3.4 (VII) Swiss Metabolomics Market
3.4 (VIII) Swedish Metabolomics Market
3.4 (IX) Russian Metabolomics Market
Exhibit 10. List of Major European Metabolomics Companies
3.5 Asia-Pacific Metabolomics Market
Exhibit 11. Metabolomics – Asia-Pacific Market Estimations & Predictions (2005-2020) in US$ Million by Country for China, India, Australia, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Exhibit 12. Metabolomics – Asia-Pacific Market Shares (2010, 2015 & 2020) for China, India, Australia, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.5 (I) Chinese Metabolomics Market
3.5 (II) Indian Metabolomics Market
3.5 (III) Australian Metabolomics Market
3.5 (II) Japanese Metabolomics Market
3.5 (IV) South Korean Metabolomics Market
Exhibit 13. List of Major Asia-Pacific Metabolomics Companies
3.6 Rest of World Metabolomics Market
Exhibit 14. Metabolomics – Rest of World Market Estimations & Predictions (2005 – 2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 15. Metabolomics – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.6 (I) Israeli Metabolomics Market
3.6 (II) South African Metabolomics Market
3.6 (III) Brazilian Metabolomics Market
Exhibit 16. List of Major Rest of World Metabolomics Companies
3.7 Company Profiles – Major Players in Metabolomics Market
AB SCIEX (USA)
BG Medicine, Inc. (USA)
Chenomx, Inc. (Canada)
Genedata AG (Switzerland)
Human Metabolome Technologies, Inc. (Japan)
Life Technologies Corporation (USA)
Metabolomic Discoveries GmbH (Germany)
Pharmaceutical Product Development, Inc. (USA)
QIAGEN NV (The Netherlands)
SiDMAP (USA)
Thermo Fisher Scientific, Inc. (USA)
Zoex Corporation (USA)
More…
3.8 Major Activities in Metabolomics Market
AB SCIEX and Indigo in Collaboration to Accelerate Adoption of Next-generation Mass Spectrometry for Clinical Research, Forensic Toxicology and Clinical Trials
Tecan and Waters in OEM Agreement
Sygnature Discovery and Cyprotex Extend Successful Strategic Alliance for a Further Two Years
Vermillion Acquires Ovarian Cancer Diagnostics Business of Correlogic Systems'
PerkinElmer Acquires Caliper Life Sciences
AB SCIEX Acquires Mass Spectrometry Division of Labindia to Expand its Presence in India
Absorption Systems Forms Pharmacokinetics Collaboration with Top Scientist
More…..
3.9 Major Product Innovations/Launches in Metabolomics Market
AB SCIEX Expands Eksigent Microflow UHPLC Capabilities
Metabolomx Develops a New Breath Test for Lung Cancer Detection
Bruker Extends its Gas Chromatography Product Portfolio with the Launch of SHS-40 Automated 93Headspace Sampler
Cyprotex Adds gADME™, a pioneering Human Pharmacokinetics based Research Service
Metabolon Launches Its Asian Facility in Shanghai
RIKEN Discovers New Method for Understanding the Dynamics of Specific Metabolites in Plant Cells
Bruker Launches amaZon speed™ Next-Generation Ion Trap Mass Spectrometers
Puracyp and Promega Combine Cell Lines and Assay Systems to Offer Complete Solution for Drug Development
More….
3.10 Analysis by Technologies
Exhibit 17. Metabolomic Technologies – Global Market Estimations & Predictions (2005-2020) in US$ Million for Combined Systems, Hardware Systems and Software Systems (Graphical Representation Included)
Exhibit 18. Metabolomic Technologies – Global Market Shares (2010, 2015 & 2020) for Combined Systems, Hardware Systems and Software Systems
3.10.1 Combined Systems – The Fastest Growing Technology
3.10.1.1 Global Metabolomics Combined Systems Market
Exhibit 19. Combined Systems* of Metabolomics - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Japan, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 20. Combined Systems* of Metabolomics - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Japan, Asia-Pacific, and Rest of World (Graphical Representation Included)
3.10.1.2 North American Metabolomics Combined Systems Market
Exhibit 21. Combined Systems of Metabolomics – North American Market Estimations & Predictions (2005-2020) in US$ Million by Country for United States and Canada (Graphical Representation Included)
Exhibit 22. Combined Systems of Metabolomics – North American Shares (2010, 2015 & 2020) by Country for United States and Canada (Graphical Representation Included)
3.10.1.2 (I) United States Metabolomics Combined Systems Market
3.10.1.2 (II) Canadian Metabolomics Combined Systems Market
3.10.1.3 European Metabolomics Combined Systems Market
Exhibit 23. Combined Systems* of Metabolomics – European Market Estimations & Predictions (2005-2020) in US$ Million by Country for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 24. Combined Systems* of Metabolomics – European Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden, Russia and Rest of Europe (Graphical Representation Included)
3.10.1.3 (I) German Metabolomics Combined Systems Market
3.10.1.3 (II) UK Metabolomics Combined Systems Market
3.10.1.3 (III) Italian Metabolomics Combined Systems Market
3.10.1.3 (IV) Belgian Metabolomics Combined Systems Market
3.10.1.3 (V) French Metabolomics Combined Systems Market
3.10.1.3 (VI) Spanish Metabolomics Combined Systems Market
3.10.1.3 (VII) Swiss Metabolomics Combined Systems Market
3.10.1.3 (VIII) Swedish Metabolomics Combined Systems Market
3.10.1.3 (IX) Russian Metabolomics Combined Systems Market
3.10.1.4 Asia-Pacific Metabolomics Combined Systems Market
Exhibit 25. Combined Systems of Metabolomics – Asia-Pacific Market Estimations & Predictions (2005-2020) in US$ Million by Country for China, India, Australia, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Exhibit 26. Combined Systems of Metabolomics – Asia-Pacific Shares (2010, 2015 & 2020) by Country for China, India, Australia, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.10.1.4 (I) Chinese Metabolomics Combined Systems Market
3.10.1.4 (II) Indian Metabolomics Combined Systems Market
3.10.1.4 (III) Australian Metabolomics Combined Systems s Market
3.10.1.4 (IV) Japanese Metabolomics Combined Systems Market
3.10.1.4 (V) South Korean Metabolomics Combined Systems s Market
3.10.1.5 Rest of World Metabolomics Combined Systems Market
Exhibit 27. Combined Systems* of Metabolomics – Rest of World Market Estimations & Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 28. Combined Systems* of Metabolomics – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.10.1.5 (I) Israeli Metabolomics Combined Systems Market
3.10.1.5 (II) South African Metabolomics Combined Systems Market
3.10.1.5 (III) Brazilian Metabolomics Combined Systems s Market
3.10.2 Hardware Systems - The Fading-out Technology
3.10.2.1 Global Metabolomics Hardware Systems Market
Exhibit 29. Hardware Systems of Metabolomics - Global Market Estimations & Predictions (2005 – 2020) by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 30. Hardware Systems of Metabolomics - Global Market Shares (2010, 2015 & 2020) by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World(Graphical Representation Included)
3.10.2.2 North American Metabolomics Hardware Systems Market
Exhibit 31. Hardware Systems of Metabolomics – North American Market (2005-2020) in US$ Million by Country for United States and Canada (Graphical Representation Included)
Exhibit 32. Hardware Systems of Metabolomics – North American Shares (2010, 2015 & 2020) by Country for United States and Canada (Graphical Representation Included)
3.10.2.2 (I) United States Metabolomics Hardware Systems Market
3.10.2.2 (II) Canadian Metabolomics Hardware Systems Market
3.10.2.3 European Metabolomics Hardware Systems Market
Exhibit 33. Hardware Systems of Metabolomics – European Market Estimations & Predictions (2005-2020) in US$ Million by Country for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 34. Hardware Systems* of Metabolomics – European Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden, Russia and Rest of Europe (Graphical Representation Included)
3.10.2.3 (I) German Metabolomics Hardware Systems Market
3.10.2.3 (II) UK Metabolomics Hardware Systems Market
3.10.2.3 (III) Italian Metabolomics Hardware Systems Market
3.10.2.3 (IV) Belgian Metabolomics Hardware Systems Market
3.10.2.3 (V) French Metabolomics Hardware Systems Market
3.10.2.3 (VI) Spanish Metabolomics Hardware Systems Market
3.10.2.3 (VII) Swiss Metabolomics Hardware Systems Market
3.10.2.3 (VIII) Swedish Metabolomics Hardware Systems Market
3.10.2.3 (IX) Russian Metabolomics Hardware Systems Market
3.10.2.4 Asia-Pacific Metabolomics Hardware Systems Market
Exhibit 35. Hardware Systems of Metabolomics – Asia-Pacific Market Estimations & Predictions (2005-2020) in US$ Million by Country for China, India, Australia, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Exhibit 36. Hardware Systems of Metabolomics – Asia-Pacific Shares (2010, 2015 & 2020) by Country for China, India, Australia, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.10.2.4 (I) Chinese Metabolomics Hardware Systems Market
3.10.2.4 (II) Indian Metabolomics Hardware Systems Market
3.10.2.4 (III) Australian Metabolomics Hardware Systems Market
3.10.2.4 (IV) Japanese Metabolomics Hardware Systems Market
3.10.2.4 (V) South Korean Metabolomics Hardware Systems Market
3.10.2.6 Rest of World Metabolomics Hardware Systems Market
Exhibit 37. Hardware Systems* of Metabolomics – Rest of World Market Estimations & Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 38. Hardware Systems* of Metabolomics – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.10.2.5 (I) Israeli Metabolomics Hardware Systems Market
3.10.2.5 (II) South African Metabolomics Hardware Systems Market
3.10.2.5 (III) Brazilian Metabolomics Hardware Systems Market
3.10.3 Software Systems – Ever Growing in Emerging Markets
3.10.3.1 Global Metabolomics Software Systems Market
Exhibit 39. Software Systems of Metabolomics - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 40. Software Systems of Metabolomics - Global Market Shares (2010, 2015 & 2020) by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World.
3.10.3.2 North American Metabolomics Software Systems Market
Exhibit 41. Software Systems of Metabolomics – North American Market (2005-2020) in US$ Million by Country for United States and Canada (Graphical Representation Included)
Exhibit 42. Software Systems of Metabolomics – North American Shares (2010, 2015 & 2020) by Country for United States and Canada (Graphical Representation Included)
3.10.3 (I) United States Metabolomics Software Systems Market
3.10.3 (II) Canadian Metabolomics Software Systems Market
3.10.3.3 European Metabolomics Software Systems Market
Exhibit 43. Software Systems of Metabolomics – European Market Estimations & Predictions (2005-2020) in US$ Million by Country for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 44. Software Systems* of Metabolomics – European Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden, Russia and Rest of Europe (Graphical Representation Included)
3.10.3.3 (I) German Metabolomics Software Systems Market
3.10.3.3 (II) UK Metabolomics Software Systems Market
3.10.3.3 (III) Italian Metabolomics Software Systems Market
3.10.3.3 (IV) Belgian Metabolomics Software Systems Market
3.10.3.3 (V) French Metabolomics Software Systems Market
3.10.3.3 (VI) Spanish Metabolomics Software Systems Market
3.10.3.3 (VII) Swiss Metabolomics Software Systems Market
3.10.3.3 (VIII) Swedish Metabolomics Software Systems Market
3.10.3.3 (IX) Russian Metabolomics Software Systems Market
3.10.3.4 Asia-Pacific Metabolomics Software Systems Market
Exhibit 45. Software Systems of Metabolomics – Asia-Pacific Market Estimations & Predictions (2005-2020) in US$ Million by Country for China, India, Australia, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Exhibit 46. Software Systems of Metabolomics – Asia-Pacific Shares (2010, 2015 & 2020) by Country for China, India, Australia, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.10.3.4 (I) Chinese Metabolomics Software Systems Market
3.10.3.4 (II) Indian Metabolomics Software Systems Market
3.10.3.4 (III) Australian Metabolomics Software Systems s Market
3.10.3.4 (IV) Japanese Metabolomics Software Systems Market
3.10.3.4 (V) South Korean Metabolomics Software Systems s Market
3.10.3.6 Rest of World Metabolomics Software Systems Market
Exhibit 47. Software Systems* of Metabolomics – Rest of World Market Estimations & Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 48. Software Systems* of Metabolomics – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.10.3.5 (I) Israeli Metabolomics Software Systems Market
3.10.3.5 (II) South African Metabolomics Software Systems Market
3.10.3.5 (III) Brazilian Metabolomics Software Systems s Market
3.11 Metabolomics – Market Outlook

4. PRODUCT/TECHNOLOGY RESEARCH
4.1 Introduction
Backdrop
Metabolomics – The Definition
Metabolism: Metabolites and Metabolome
Metabolites
Metabolome
Metabolic Profiling
Metabolomics and Metabonomics
History of Metabolomics
Metabolomic Profiling
Separation Methods
Detection Methods
Metabolomic Profiling –Applications
Toxicity Assessment/Toxicology
Functional Genomics
Human Nutrition Metabolome
Metabolomics and Human Health
Metabolomic Techniques for Genetic Mapping
Human Metabolic Diagnosis
Metabolomics in Human Nutrition – Prospects and Experiments
The Human Nutrition Metabolome Generation
Pattern-Recognition Methods and Human Nutrition
Nutrition Evaluation with Pharmacology and Toxicology
Metabolomic Profiling – Tools
HiRes (High Resolution Spectroscopy)
Computer Simulation of Metabolism
Computer Simulation and the Design of Drugs
Cheminformatics
The Human Metabolome Project
Human Metabolome Database
Importance of Metabolomic Studies
Systems Biology or Integrative Biology
System Biology and its Inside View
Biomolecular Networks
Metabolic Activity Preservation in Lyophilized Human Erythrocytes
Metabolic flux Ratio Study on Escherichia coli Mutants Using GC-MS Method
Metabolite Profiling – The Technologies
The LC-MS Technique
Liquid Chromatographic Radioactivity Detection Techniques
Structural Genomics in Combination with Metabolic Profiling
Techniques for Redox Metabolic Profiling
How Metabolites Affect Food
Metabolomics - Related with other Omics?
Proteomics, Genomics and Metabolomics
Functional Genomics
The Shortcomings/Delays in Functional Genomics Strategies
Proteomics
Lipidomics
Definition
Concept of Lipidomics
Traditional Analysis of Lipids
Lipidomics Aids Treatment of CNS Related Diseases
Glycomics
Study of Glycobiology - Analytical High-Throughput Technologies
Transcriptomics
Arabidopsis Thaliana
Signal Transduction Process
Dietary Leucine Excess
Analysis of Metabolic Pathways
Types of Metabolic Pathways Databases
MMCD
BRENDA
EMP
Enzyme Nomenclature Database
IntEnz
Kinase Pathway Database
PhosphaBase
PRECISE
TECRDB
BOCD
EcoCyc
KEGG Metabolic Pathways
Boehringer Mannheim - Biochemical Pathways
Environmental Metabolomics
Components for the Study of Metabolomics
Challenges to Environmental Metabolomics
Advantages of Metabolomics
Other Side of the Coin
Metabolomics to Probe GM foods
4.2 Metabolomics Technologies
Sophisticated Analytical Tools Required in Metabolomics
Scope for Growth in NMR-based Analysis
The Bottom-up Approach
Blood as a Central Focus Theme
An Individualized Approach to Metabolomics
Categorization of Metabolomics Technologies
Mass Spectrometry
Applications of Mass Spectrometers
Protein Detection and Analysis
Protein Quantitation
Protein Structure Probing
Space Exploration
Respiratory Gas Monitoring
Isotope Ratio Evaluation
Exposure and Burial Dating
Trace Gas Analysis
Pharmacokinetics
Metabolites Identification and Biomarkers Development
Use of Metabolomic to Improve Detection of Cancers
Metabolomics in Cancer Research
Nuclear Magnetic Resonance
Fourier Spectroscopy
Multi-Dimensional – A Type of FT-NMR
NMR Based Metabolomics
Applications of NMR
Liquid Chromatography/Gas Chromatography
High Performance Liquid Chromatography
Lab-on-a-Chip
Capillary Electrophoresis
Electrochemical Array
Application of Electrochemical Array Detection in Metabolomics
Fourier-Transform Infrared Spectroscopy
Qualitative Analysis with FT – IR7
Challenges for Metabolomics
4.3 Metabolomics – A Pharma and Healthcare Perspective
Metabolomics - Significance of Individual Health
Need for Awareness of Balanced Diet
Creation of Basic Structure
Creation Stage
Development of Technologies
Database Collection on Personalized Metabolites Health
Innovation Stage
Metabolism’s Role in Physical Condition
Pathways Ideal for Classifying Targets and Techniques
Execution Stage
Execution of Personalized Evaluation Technologies
Clinical Chemistry and Metabolomics
Metabolomics in Biomarker Identification
Metabolite Biomarkers
Study of Biomarker Metabolites in Oryza Sativa (Rice)
Limitations of Metabolite Biomarkers
Personalized Medicine with Metabolomics
Pharmaco-Metabonomics
Application of Metabolomics in Transplantation
Exhibit 49. Reported Frequencies of Organ Transplantations (2007): Percentage Breakdown of Frequencies for Kidney, Liver, Heart, Pancreas and Lung Transplantations (Graphical Representation Included)
Role of Metabolomics in Transplantation of Various Organs
Increased Concentration of Metabolite Related to Organ Transplantation
Decreased Concentration of Metabolite Related to Organ Transplantation
Kidney Transplantation
Liver Transplantation
Heart Transplantation
Metabolomics – In the Process of Drug Discovery
Metabolomics to Save Time and Cost in Initial Stages
Distinguishing Varieties of Animal Phenotypes
Use in Personalized Nutrition Research and Clinical Field
Challenges Associated with Metabolomics for Diabetes Research
Biomarker Detection
Metabolic Profiling Approach for Biomarker Discovery
ESI-LC/MS Use in Identifying Biomarkers in Plant Extracts
Metabolic Profiles and Biomarkers Determine Toxic Drug Effects
4.4 Metabolomics – Research Briefs
Beneficial Effects of Nuts in Controlling Metabolic Disorders
Advion Developing H4 Method for Clopidogrel and the Inactive Metabolites
Modern Technologies in Detection and Quantification of Protein Biomarkers - Mass Spectrometry and Chip LC Technology
Gender-Specific Drugs Developed Through Metabolomics
Metabolon Conducts Research into Dietary Leucine
Advancement in QTRAP Technology
SWATH™ Acquisition technology and MRMAtlas
More…..

5. CORPORATE DIRECTORY

6. PATENTS INFORMATION

Exhibit 1. Metabolomics - Global Market Estimations & Predictions (2005 - 2020) in US$ Million (Graphical Representation Included)
Exhibit 2. List of Major Metabolomics Companies
Exhibit 3. Metabolomics - Global Market Estimations & Predictions (2005 - 2020) in US$ Million by Geographic Region for North America, Europe, Japan, Asia-Pacific, and Rest of World (Graphical Representation Included)
Exhibit 4. Metabolomics – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Japan, Asia-Pacific, and Rest of World (Graphical Representation Included)
Exhibit 5. Metabolomics – North American Market Estimations & Predictions (2005 - 2020) in US$ Million by Country for United States, and Canada (Graphical Representation Included)
Exhibit 6. Metabolomics – North American Market Shares (2010, 2015 & 2020) by Country for United States, and Canada (Graphical Representation Included)
Exhibit 7. List of Major North American Metabolomics Companies
Exhibit 8. Metabolomics – European Market Estimations & Predictions (2005-2020) in US$ Million by Country for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 9. Metabolomics – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 10. List of Major European Metabolomics Companies
Exhibit 11. Metabolomics – Asia-Pacific Market Estimations & Predictions (2005-2020) in US$ Million by Country for China, India, Australia, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Exhibit 12. Metabolomics – Asia-Pacific Market Shares (2010, 2015 & 2020) for China, India, Australia, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Exhibit 13. List of Major Asia-Pacific Metabolomics Companies
Exhibit 14. Metabolomics – Rest of World Market Estimations & Predictions (2005 – 2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 15. Metabolomics – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 16. List of Major Rest of World Metabolomics Companies
Exhibit 17. Metabolomic Technologies – Global Market Estimations & Predictions (2005-2020) in US$ Million for Combined Systems, Hardware Systems and Software Systems (Graphical Representation Included)
Exhibit 18. Metabolomic Technologies – Global Market Shares (2010, 2015 & 2020) for Combined Systems, Hardware Systems and Software Systems
Exhibit 19. Combined Systems* of Metabolomics - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Japan, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 20. Combined Systems* of Metabolomics - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Japan, Asia-Pacific, and Rest of World (Graphical Representation Included)
Exhibit 21. Combined Systems of Metabolomics – North American Market Estimations & Predictions (2005-2020) in US$ Million by Country for United States and Canada (Graphical Representation Included)
Exhibit 22. Combined Systems of Metabolomics – North American Shares (2010, 2015 & 2020) by Country for United States and Canada (Graphical Representation Included)
Exhibit 23. Combined Systems* of Metabolomics – European Market Estimations & Predictions (2005-2020) in US$ Million by Country for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 24. Combined Systems* of Metabolomics – European Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 25. Combined Systems of Metabolomics – Asia-Pacific Market Estimations & Predictions (2005-2020) in US$ Million by Country for China, India, Australia, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Exhibit 26. Combined Systems of Metabolomics – Asia-Pacific Shares (2010, 2015 & 2020) by Country for China, India, Australia, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Exhibit 27. Combined Systems* of Metabolomics – Rest of World Market Estimations & Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 28. Combined Systems* of Metabolomics – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 29. Hardware Systems of Metabolomics - Global Market Estimations & Predictions (2005 – 2020) by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 30. Hardware Systems of Metabolomics - Global Market Shares (2010, 2015 & 2020) by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World(Graphical Representation Included)
Exhibit 31. Hardware Systems of Metabolomics – North American Market (2005-2020) in US$ Million by Country for United States and Canada (Graphical Representation Included)
Exhibit 32. Hardware Systems of Metabolomics – North American Shares (2010, 2015 & 2020) by Country for United States and Canada (Graphical Representation Included)
Exhibit 33. Hardware Systems of Metabolomics – European Market Estimations & Predictions (2005-2020) in US$ Million by Country for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden, Russia and Rest of Europe(Graphical Representation Included)
Exhibit 34. Hardware Systems* of Metabolomics – European Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 35. Hardware Systems of Metabolomics – Asia-Pacific Market Estimations & Predictions (2005-2020) in US$ Million by Country for China, India, Australia, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Exhibit 36. Hardware Systems of Metabolomics – Asia-Pacific Shares (2010, 2015 & 2020) by Country for China, India, Australia, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Exhibit 37. Hardware Systems* of Metabolomics – Rest of World Market Estimations & Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 38. Hardware Systems* of Metabolomics – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 39. Software Systems of Metabolomics - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 40. Software Systems of Metabolomics - Global Market Shares (2010, 2015 & 2020) by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World.
Exhibit 41. Software Systems of Metabolomics – North American Market (2005-2020) in US$ Million by Country for United States and Canada (Graphical Representation Included)
Exhibit 42. Software Systems of Metabolomics – North American Shares (2010, 2015 & 2020) by Country for United States and Canada (Graphical Representation Included)
Exhibit 43. Software Systems of Metabolomics – European Market Estimations & Predictions (2005-2020) in US$ Million by Country for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 44. Software Systems* of Metabolomics – European Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 45. Software Systems of Metabolomics – Asia-Pacific Market Estimations & Predictions (2005-2020) in US$ Million by Country for China, India, Australia, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Exhibit 46. Software Systems of Metabolomics – Asia-Pacific Shares (2010, 2015 & 2020) by Country for China, India, Australia, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Exhibit 47. Software Systems* of Metabolomics – Rest of World Market Estimations & Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 48. Software Systems* of Metabolomics – Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
Exhibit 49. Reported Frequencies of Organ Transplantations (2007): Percentage Breakdown of Frequencies for Kidney, Liver, Heart, Pancreas and Lung Transplantations (Graphical Representation Included)

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +